The present invention relates to gastroretentive dosage forms of gamma aminobutyric acid (GABA) analogs, and to processes for preparation of the same. The present invention provides gastroretentive dosage forms comprising GABA analog, at least one swelling agent and at least one non-swelling release retardant.